From Margins to Mainstream: Key Milestones & Metrics in Psychedelic Clinical Research, Significance of the Recent FDA Guidance, & Outlooks for the Near Future
Time: 11:15 am
day: Conference Day One
- A review of the key milestones and metrics in psychedelic clinical trials from past to present.
- Highlights from the recent FDA draft guidance
- Surveying the landscape for future trials and approvals